WO1999016429A3 - Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases - Google Patents
Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases Download PDFInfo
- Publication number
- WO1999016429A3 WO1999016429A3 PCT/EP1998/005567 EP9805567W WO9916429A3 WO 1999016429 A3 WO1999016429 A3 WO 1999016429A3 EP 9805567 W EP9805567 W EP 9805567W WO 9916429 A3 WO9916429 A3 WO 9916429A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapy
- liver diseases
- combination
- ursodeoxycholic acid
- cholestatic liver
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
According to the invention it was unexpectedly found that budesonide can be used for the treatment of cholestatic liver diseases such as PBC, PSC and AC. In particular budesonide is highly effective when administered together with ursodeoxycholic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9806250-6A BR9806250A (en) | 1997-09-26 | 1998-09-02 | Busesonde isolated or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases. |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19742612.3 | 1997-09-26 | ||
DE29717252.2 | 1997-09-26 | ||
DE19742612A DE19742612A1 (en) | 1997-09-26 | 1997-09-26 | Budesonide for the treatment of cholestatic liver diseases |
DE29717252U DE29717252U1 (en) | 1997-09-26 | 1997-09-26 | Drug kit consisting of a budesonide-containing and an ursodeoxycholic acid-containing drug for the treatment of cholestatic liver diseases |
US08/940,211 US5858998A (en) | 1997-09-26 | 1997-09-30 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
CA002216887A CA2216887C (en) | 1997-09-26 | 1997-09-30 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
US08/940,211 | 1997-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999016429A2 WO1999016429A2 (en) | 1999-04-08 |
WO1999016429A3 true WO1999016429A3 (en) | 2001-12-20 |
Family
ID=27427393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/005567 WO1999016429A2 (en) | 1997-09-26 | 1998-09-02 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases |
Country Status (2)
Country | Link |
---|---|
BR (1) | BR9806250A (en) |
WO (1) | WO1999016429A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3760203A1 (en) | 2019-07-03 | 2021-01-06 | Medizinische Universität Graz | Medicament for prevention or treatment of a metabolic disorder |
-
1998
- 1998-09-02 WO PCT/EP1998/005567 patent/WO1999016429A2/en active Application Filing
- 1998-09-02 BR BR9806250-6A patent/BR9806250A/en not_active Application Discontinuation
Non-Patent Citations (8)
Also Published As
Publication number | Publication date |
---|---|
BR9806250A (en) | 2000-01-25 |
WO1999016429A2 (en) | 1999-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2216887A1 (en) | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases | |
WO2001062954A8 (en) | Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents | |
IL144294A0 (en) | P53 inhibitors and therapeutic use of the same | |
HUP0004133A3 (en) | Combined use of progestin and polycarboxilic acid for the preparation of pharmaceutical compositions for controlled bleeding | |
IL114586A (en) | Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same | |
AU3218197A (en) | Natural progesterone for the treatment of side effects of progestins and progesterone analogues | |
IL153648A0 (en) | Novel testosterone ester formulation for human use | |
AU2002345255A1 (en) | Composition comprising soy and use thereof in the prevention and/or treatment of various diseases | |
AU2300001A (en) | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
PL345364A1 (en) | The use of valproic acid analog for the treatment and prevention of migraine and affective illness | |
AU2003278434A1 (en) | Cardiovascular protection using anti-aldosteronic progestins | |
EP1406648A4 (en) | The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders | |
WO1999016429A3 (en) | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases | |
GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
HUP0000785A3 (en) | Ointment for the treatment of burns and other skin diseases | |
AU3247201A (en) | Gene therapy to promote angiogenesis and/or the treatment of heart failure | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
WO2003007876A3 (en) | N-fatty acid-amino acid conjugates and therapeutic uses | |
AU3356000A (en) | L-arginine based formulations for treating diseases and methods of using same | |
AU2003250001A1 (en) | Use of compositions comprising benzoyl peroxide and glycyrrhetinic acid for the treatment of acne | |
GB9921985D0 (en) | Medicaments containing pantothenic acid | |
AU2002214950A1 (en) | Determination of the ability of patients to respond to tumour treatment | |
AU2001255126A1 (en) | The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure | |
AU2003271442A1 (en) | Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): BR MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/004829 Country of ref document: MX |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): BR MX |